Schonfeld Strategic Advisors’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History
Bought
Maintained
Sold
Schonfeld Strategic Advisors's IMGO Position: Q1 2023 in Review
Schonfeld Strategic Advisors sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 568,293 shares — an estimated $20.4M sold.
Schonfeld Strategic Advisors first reported a position in IMGO in Q4 2022 and held it in 1 quarter. The position peaked at $20.4M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.
- Schonfeld Strategic Advisors reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
- Schonfeld Strategic Advisors sold 568,293 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $20.4M.
- Schonfeld Strategic Advisors first reported a position in Imago BioSciences, Inc. Common stock in Q4 2022 and held it in 1 quarter.
- Schonfeld Strategic Advisors's Imago BioSciences, Inc. Common stock position peaked at $20.4M in Q4 2022.
- 0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2023, filed 15 May 2023.